Devika Ranade
About Devika Ranade
Devika Ranade is a Variant Analyst specializing in clinical data integration and management for cancer genetics. She holds a B.Sc in Microbiology, an M.Sc in Virology, and a PhD in Biochemistry and Molecular Biology, and has worked at PierianDx since 2018.
Work at PierianDx
Devika Ranade has been employed at PierianDx since 2018, serving as a Variant Analyst. In this role, she focuses on clinical data integration and management, particularly in the field of cancer genetics. Her work involves analyzing genetic variants to support clinical decision-making and improve patient outcomes. Based in the Pune Area of India, she contributes to the company's mission of advancing precision medicine through the use of genomic data.
Education and Expertise
Devika Ranade has a robust educational background in the life sciences. She earned her Bachelor of Science (B.Sc) in Microbiology from Abasaheb Garware College, where she studied from 2005 to 2008. Following this, she completed her Master of Science (M.Sc) in Virology at the National Institute of Virology from 2008 to 2010. Devika further advanced her studies by obtaining a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology from the Indian Institute of Science Education & Research (IISER), Pune, where she studied from 2010 to 2017. Her expertise includes laboratory Molecular Cytogenetics and Confocal Microscopy.
Background
Devika Ranade has a strong foundation in microbiological sciences, which she developed during her undergraduate studies. Her academic journey continued with a focus on virology and later biochemistry and molecular biology, culminating in her PhD. This diverse background equips her with a comprehensive understanding of the molecular mechanisms underlying genetic variations, particularly in cancer genetics.
Specialization in Cancer Genetics
As a Variant Analyst, Devika Ranade specializes in the integration and management of clinical data related to cancer genetics. Her role involves the assessment of genetic variants, which is crucial for understanding the genetic basis of cancer and for developing targeted therapies. This specialization is supported by her extensive academic training and practical experience in molecular biology and cytogenetics.